Pfizer ends neuroscience discovery programme, including research into Alzheimer ’s disease treatment – Alzheimer’s Society comment

Pfizer has announced that it will be ending its neuroscience discovery and early development efforts, an area which includes research into drug development for Alzheimer ’s disease.
Source: Alzheimers Society - Category: Geriatrics Source Type: news